doi: Zhu, B., Gostoli, S., Benasi, G., Patierno, C., Petroni, M.L., Nuccitelli, C., Marchesini, G., Fava, G.A
Dose increases within the range determined by the prescribing physician may be considered for patients who are tolerating the medication well, based on provider assessment
From a mechanistic perspective, GLP-1RAs like exenatide notably decreased the percentage of Th17 cells while promoting the proliferation of Tregs by influencing the signaling cascade encompassing phosphatidylinositol 3-kinase (PI3K), protein kinase B (AKT), along with forkhead box O1 (FoxO1) [147]
Neither scenario is what the retatrutide dosing protocols were designed around
Elstak, E
Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, and nearly 99% remained diabetes-free at 176 weeks | Eli Lilly and Company